Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (9498)	11/17/2003 11:32:09 AM
From: rkrw	Read Replies (1) \| Respond to of 52153

Out of curiosity I calculated the compounded rates of returns for 8 long time, varying success, product approved or late stage product biotech companies since IPO. Not sure what it means looking forward but... AMLN: IPO 1/17/92 $20.00..cpd rate of return 1.7% VRTX: IPO 7/24/91 $4.50...cpd rate of return 5.5% SEPR: IPO 9/23/91 $7.00...cpd rate of return 10.6% MLNM: IPO 5/7/96 $4.75....cpd rate of return 17.5% GENZ: IPO 3/26/90 $3.87...cpd rate of return 19.1% NBIX: IPO 5/23/96 $12.00..cpd rate of return 20.5% MEDI: IPO 5/8/91 $1.63...cpd rate of return 22.5% GILD: IPO 1/22/92 $4.31...cpd rate of return 23.1% AMGN: IPO 9/7/84 $0.10....cpd rate of return 39.5% For a long time loser (I'm sure there are plenty :-) LJPC: IPO 6/3/94 $5.50...cpd rate of return -4% TKTX: IPO 10/17/96 $15.00..cpd rate of retrn -2%